The group’s principle activity is to provide diagnostic, treatment planning, facility management, and imaging integration systems and software. The group’s Proton therapy provides tumor control and vastly diminishes post-treatment side effects when compared to conventional external beam therapies, surgery and chemotherapy. The group operates from United States.
